Navegar

Colección

Datos Estadísticas

Lista de

Neoplasm Metastasis
18
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity" (2018) Song, M.;Sandoval, T.A.;Chae, C.-S. (...)Cubillos-Ruiz, J.R. Nature. 562(7727):423-428
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors" (2016) Wu, Y.;Tedesco, L.;Lucia, K. (...)Stalla, G.K. Oncotarget. 7(36):57878-57893
"Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases" (2014) Martinez, L.M.;Vallone, V.B.F.;Labovsky, V. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 31(2):213-232
"Glycans and galectins in prostate cancer biology, angiogenesis and metastasis" (2014) Compagno, D.;Gentilini, L.D.;Jaworski, F.M. (...)Laderach, D.J. Glycobiology. 24(10):899-906
"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"1,2,4-Triazole d-ribose derivatives: Design, synthesis and antitumoral evaluation" (2012) Avanzo, R.E.;Anesini, C.;Fascio, M.L. (...)D'Accorso, N.B. European Journal of Medicinal Chemistry. 47(1):104-110
"Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential" (2006) Urtreger, A.J.;Werbajh, S.E.;Verrecchia, F. (...)Bal De Kier Joffé, E.D. Oncology Reports. 16(6):1403-1410
"Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition" (1995) Bertolesix, G.E.; de Cidre, L.L.; de Lustig, E.S.; Eiján, A.M. Cancer Letters. 90(2):123-131
"Biologic, Immunocytochemical, and Cytogenetic Characterization of Two New Human Melanoma Cell Lines: IIB‐MEL‐LES and IIB‐MEL‐IAN" (1995) KAIRIYAMA, C.;SLAVUTSKY, I.;LARRIPA, I. (...)MORDOH, J. Pigment Cell Research. 8(3):121-131
"Cancer and BCG " (1981) Rumi, L.S. Acta Physiologica Latino-Americana. 31(1):25-34